Alternative to Statins? Study Backs Cholesterol Drug Vytorin

November 18, 2014 6:13 PM

2 0

Merck is getting the study results they hoped for from Vytorin. The American Heart Association has wrapped up a six-year study involving 18,000 participants into whether alternatives to statin drugs could be used to not only lower LDL (bad cholesterol), but to also reduce occurrences of heart attacks and strokes.

While the study was funded by Merck, the American Heart Association was allowed to publish findings free of interference. The findings will help millions of Americans who cannot tolerate statins or do not respond to them.

Read more

To category page